Amendment of rule 43A of the Drugs Rules 1945 to include ICD Tihi Indore as port of entry for medical products

## Policy Analysis Report: Amendment to the Drugs Rules, 1945 **1. Executive Summary:** This report analyzes a proposed amendment to the Drugs Rules, 1945, as published in the Gazette of India on September 1, 2021. The amendment, as outlined in the draft rules, specifically concerns a modification to rule 43A regarding Inland Container Depots. The amendment aims to update the specified locations within rule 43A. Interested parties are invited to submit objections and suggestions within thirty days of the gazette's publication. This report outlines the key provisions of the amendment, its likely rationale, and potential impact. **2. Introduction:** This report provides an analysis of the draft amendment to the Drugs Rules, 1945, based solely on the information provided in the official notification published in the Gazette of India on September 1, 2021. The report aims to inform stakeholders within the pharmaceutical industry and related sectors about the proposed change and its potential implications. **3. Policy Overview:** * **Amendment:** This document proposes an amendment to the existing Drugs Rules, 1945. * **Core Objective:** The core objective of this *specific* amendment, as inferred from the provided text, is to update the list of specified Inland Container Depots mentioned in rule 43A of the Drugs Rules, 1945. **4. Background and Rationale:** * **Rationale for Amendment:** The likely reason for this specific amendment is to reflect changes in infrastructure or operational changes related to Inland Container Depots involved in the import/export of drugs. The original rule 43A likely contained an outdated reference, and this amendment aims to update the regulation to accurately reflect current operational realities. It suggests the inclusion of a new Inland Container Depot at Tihi is necessary. **5. Key Provisions / Changes:** * **Specific Part of Original Policy Changed:** The amendment targets rule 43A of the Drugs Rules, 1945. * **New Rule/Provision:** The existing wording "Inland Container Depot Dhannad" in rule 43A is to be replaced with "Inland Container Depot at Dhannad and Tihi." * **Difference/Effect of Change:** The change expands the scope of rule 43A to explicitly include the Inland Container Depot at Tihi, in addition to the existing Inland Container Depot at Dhannad. This means that any regulations or procedures governed by rule 43A will now apply to both locations, specifically impacting the import and export procedures for pharmaceuticals at the Tihi Depot. **6. Target Audience and Stakeholders:** The primary target audience and stakeholders directly affected by this amendment include: * Pharmaceutical manufacturers and distributors who utilize the Inland Container Depots at Dhannad and Tihi for import/export activities. * Customs officials and regulatory bodies responsible for overseeing the import and export of drugs at these depots. * Operators and management of the Inland Container Depots at Dhannad and Tihi. **7. Implementation Aspects (Inferred):** * **Responsible Agency/Bodies:** The Ministry of Health and Family Welfare, specifically the Department of Health and Family Welfare, is responsible for implementing and overseeing the amendment. The Drugs Technical Advisory Board was consulted. * **Timelines/Procedures:** A period of thirty days from the date of publication (September 1, 2021) is provided for stakeholders to submit objections and suggestions. The amendment will come into force on the date of its final publication in the Official Gazette. No specific procedures for implementing the change at the depot level are mentioned in the text. **8. Expected Outcomes / Impact of Changes:** The likely intended outcome of this amendment is to: * Ensure regulatory compliance by explicitly including the Inland Container Depot at Tihi within the scope of rule 43A. * Facilitate the smooth import/export of drugs through the Inland Container Depot at Tihi, enabling it to operate under the same regulatory framework as Dhannad. * Potentially streamline customs and regulatory processes at both depots due to the updated regulation. The impact of this amendment will likely be felt mostly by companies using the Tihi depot, as they will be now be regulated under Rule 43A. **9. Conclusion:** The proposed amendment to the Drugs Rules, 1945, specifically rule 43A, aims to update the list of specified Inland Container Depots to include the Inland Container Depot at Tihi. This update reflects evolving infrastructure or operational changes in the logistics of drug import and export. Stakeholders should carefully review the amendment and submit any objections or suggestions within the specified timeframe. This amendment ensures regulatory coverage for the Tihi depot, facilitating smoother operations for pharmaceutical companies utilizing it.

Key Entities Referenced